Rodica Pop-Busui - Publications

Affiliations: 
The University of Toledo 
Area:
Medicine and Surgery, Neuroscience Biology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, Cutler JA, Grimm R, Pedley C, Peterson K, Pop-Busui R, Sperl-Hillen J, Cushman WC. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Hypertension (Dallas, Tex. : 1979). PMID 27504006 DOI: 10.1161/Hypertensionaha.116.07474  0.4
2016 Hotaling JM, Sarma AV, Patel DP, Braffett BH, Cleary PA, Feldman E, Herman WH, Martin CL, Jacobson AM, Wessells H, Pop-Busui R. Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. Diabetes Care. PMID 27352953 DOI: 10.2337/Dc16-0059  0.4
2016 Duvernoy CS, Raffel DM, Swanson SD, Jaiswal M, Mueller G, Ibrahim ES, Pennathur S, Plunkett C, Stojanovska J, Brown MB, Pop-Busui R. Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 27146882 DOI: 10.1007/S12350-016-0434-2  0.4
2016 Wheelock KM, Jaiswal M, Martin CL, Fufaa GD, Weil EJ, Lemley KV, Yee B, Feldman E, Brosius FC, Knowler WC, Nelson RG, Pop-Busui R. Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. Journal of Diabetes and Its Complications. PMID 27041674 DOI: 10.1016/J.Jdiacomp.2016.03.008  0.4
2016 Stem MS, Dunbar GE, Jackson GR, Farsiu S, Pop-Busui R, Gardner TW. Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus. Eye (London, England). PMID 27034201 DOI: 10.1038/Eye.2016.48  0.4
2016 Jaiswal M, Fufaa GD, Martin CL, Pop-Busui R, Nelson RG, Feldman EL. Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes. Diabetes Care. PMID 26908916 DOI: 10.2337/Dc16-0082  0.4
2016 Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL. Inflammation as a Therapeutic Target for Diabetic Neuropathies. Current Diabetes Reports. 16: 29. PMID 26897744 DOI: 10.1007/S11892-016-0727-5  0.4
2015 Kim C, Pop-Busui R, Braffett B, Cleary PA, Bebu I, Wessells H, Orchard T, Sarma AV. Testosterone Concentrations and Cardiovascular Autonomic Neuropathy in Men with Type 1 Diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC). The Journal of Sexual Medicine. PMID 26559501 DOI: 10.1111/Jsm.13029  0.4
2015 DeMill DL, Hussain M, Pop-Busui R, Shtein RM. Ocular surface disease in patients with diabetic peripheral neuropathy. The British Journal of Ophthalmology. PMID 26500330 DOI: 10.1136/Bjophthalmol-2015-307369  0.4
2015 Kim NH, Lee J, Kim TJ, Kim NH, Choi KM, Baik SH, Choi DS, Pop-Busui R, Park Y, Kim SG. Body Mass Index and Mortality in the General Population and in Subjects with Chronic Disease in Korea: A Nationwide Cohort Study (2002-2010). Plos One. 10: e0139924. PMID 26462235 DOI: 10.1371/Journal.Pone.0139924  0.4
2015 Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL, Pop-Busui R. Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. Journal of Diabetes and Its Complications. PMID 26264399 DOI: 10.1016/J.Jdiacomp.2015.07.013  0.4
2015 Orlov S, Cherney DZ, Pop-Busui R, Lovblom LE, Ficociello LH, Smiles AM, Warram JH, Krolewski AS, Perkins BA. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 1136-44. PMID 26092828 DOI: 10.2215/Cjn.11441114  0.4
2015 Pop-Busui R, Hotaling J, Braffett BH, Cleary PA, Dunn RL, Martin CL, Jacobson AM, Wessells H, Sarma AV. Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. The Journal of Urology. 193: 2045-51. PMID 25584994 DOI: 10.1016/J.Juro.2014.12.097  0.4
2014 Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Current Diabetes Reports. 14: 528. PMID 25139473 DOI: 10.1007/S11892-014-0528-7  0.4
2014 Wrobel JS, Ammanath P, Le T, Luring C, Wensman J, Grewal GS, Najafi B, Pop-Busui R. A novel shear reduction insole effect on the thermal response to walking stress, balance, and gait. Journal of Diabetes Science and Technology. 8: 1151-6. PMID 25107709 DOI: 10.1177/1932296814546528  0.4
2014 Stem MS, Hussain M, Lentz SI, Raval N, Gardner TW, Pop-Busui R, Shtein RM. Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus. Journal of Diabetes and Its Complications. 28: 658-61. PMID 25044236 DOI: 10.1016/J.Jdiacomp.2014.06.007  0.4
2014 Jaiswal M, McKeon K, Comment N, Henderson J, Swanson S, Plunkett C, Nelson P, Pop-Busui R. Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes. Diabetes Care. 37: 2616-21. PMID 24973438 DOI: 10.2337/Dc14-0445  0.4
2014 Biessels GJ, Bril V, Calcutt NA, Cameron NE, Cotter MA, Dobrowsky R, Feldman EL, Fernyhough P, Jakobsen J, Malik RA, Mizisin AP, Oates PJ, Obrosova IG, Pop-Busui R, Russell JW, et al. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). Journal of the Peripheral Nervous System : Jpns. 19: 77-87. PMID 24934510 DOI: 10.1111/Jns5.12072  0.4
2014 Jaiswal M, Schinske A, Pop-Busui R. Lipids and lipid management in diabetes. Best Practice & Research. Clinical Endocrinology & Metabolism. 28: 325-38. PMID 24840262 DOI: 10.1016/J.Beem.2013.12.001  0.4
2014 Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 129: e460-1. PMID 24753557 DOI: 10.1161/Circulationaha.113.008033  0.4
2014 Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 37: 31-8. PMID 24356595 DOI: 10.2337/Dc13-2114  0.4
2014 Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, McInnis MI, Grove TB, Brook RD, Zöllner SK, Ellingrod VL. Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disorders. 16: 277-88. PMID 24330321 DOI: 10.1111/Bdi.12160  0.4
2013 Jaiswal M, Lauer A, Martin CL, Bell RA, Divers J, Dabelea D, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Rodriguez BL, Pop-Busui R, Feldman EL. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Diabetes Care. 36: 3903-8. PMID 24144652 DOI: 10.2337/Dc13-1213  0.4
2013 Hur J, Sullivan KA, Callaghan BC, Pop-Busui R, Feldman EL. Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy. Diabetes Care. 36: 4043-9. PMID 24101696 DOI: 10.2337/Dc12-2530  0.4
2013 Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 128: 785-94. PMID 23857320 DOI: 10.1161/Circulationaha.112.000678  0.4
2013 Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Escobedo J, Green J, Palumbo P, Perkins BA, Whitehouse F, Jones TL. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care. 36: 3208-15. PMID 23757426 DOI: 10.2337/Dc13-0012  0.4
2013 Pop-Busui R, Stevens MJ, Raffel DM, White EA, Mehta M, Plunkett CD, Brown MB, Feldman EL. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia. 56: 1835-44. PMID 23740194 DOI: 10.1007/S00125-013-2942-9  0.4
2013 Maahs DM, Caramori L, Cherney DZI, Galecki AT, Gao C, Jalal D, Perkins BA, Pop-Busui R, Rossing P, Mauer M, Doria A. Uric acid lowering to prevent kidney function loss in diabetes: The preventing early renal function loss (PERL) allopurinol study Current Diabetes Reports. 13: 550-559. PMID 23649945 DOI: 10.1007/S11892-013-0381-0  0.4
2013 Marsh CA, Berent-Spillson A, Love T, Persad CC, Pop-Busui R, Zubieta JK, Smith YR. Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study. Fertility and Sterility. 100: 200-7.e1. PMID 23557757 DOI: 10.1016/J.Fertnstert.2013.02.054  0.4
2013 Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC. Determinants of weight gain in the action to control cardiovascular risk in diabetes trial. Diabetes Care. 36: 2162-8. PMID 23412077 DOI: 10.2337/Dc12-1391  0.4
2013 Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima JA, Bluemke DA. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). Journal of the American College of Cardiology. 61: 447-54. PMID 23265339 DOI: 10.1016/J.Jacc.2012.10.028  0.4
2012 Burghardt KJ, Pop-Busui R, Bly MJ, Grove TB, Taylor SF, Ellingrod VL. The influence of the brain-derived neurotropic factor Val66Met genotype and HMG-CoA reductase inhibitors on insulin resistance in the schizophrenia and bipolar populations. Clinical and Translational Science. 5: 486-90. PMID 23253673 DOI: 10.1111/Cts.12001  0.4
2012 Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, Sansing VV, Beller GA, Pop-Busui R, Taillefer R, Chaitman BR, Gibbons RJ, Heo J, Iskandrian AE. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 19: 658-69. PMID 22527794 DOI: 10.1007/S12350-012-9548-3  0.4
2012 Petrou M, Pop-Busui R, Foerster BR, Edden RA, Callaghan BC, Harte SE, Harris RE, Clauw DJ, Feldman EL. Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. Academic Radiology. 19: 607-12. PMID 22463961 DOI: 10.1016/J.Acra.2012.02.004  0.4
2012 Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabetic Medicine : a Journal of the British Diabetic Association. 29: 937-44. PMID 22417277 DOI: 10.1111/J.1464-5491.2012.03644.X  0.4
2012 Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, Brook RD, Zöllner SK, Pop-Busui R. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. Journal of Clinical Psychopharmacology. 32: 261-5. PMID 22370993 DOI: 10.1097/Jcp.0B013E3182485888  0.4
2012 Chandra P, Sands RL, Gillespie BW, Levin NW, Kotanko P, Kiser M, Finkelstein F, Hinderliter A, Pop-Busui R, Rajagopalan S, Saran R. Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 700-9. PMID 21765187 DOI: 10.1093/Ndt/Gfr340  0.4
2011 Rawlings RA, Shi H, Yuan LH, Brehm W, Pop-Busui R, Nelson PW. Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©). Diabetes Technology & Therapeutics. 13: 1241-8. PMID 21932986 DOI: 10.1089/Dia.2011.0099  0.4
2011 Gianchandani RY, Saberi S, Zrull CA, Patil PV, Jha L, Kling-Colson SC, Gandia KG, DuBois EC, Plunkett CD, Bodnar TW, Pop-Busui R. Evaluation of hemoglobin A1c criteria to assess preoperative diabetes risk in cardiac surgery patients. Diabetes Technology & Therapeutics. 13: 1249-54. PMID 21854260 DOI: 10.1089/Dia.2011.0074  0.4
2011 Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes/Metabolism Research and Reviews. 27: 639-53. PMID 21695768 DOI: 10.1002/Dmrr.1239  0.4
2011 Bernardi L, Spallone V, Stevens M, Hilsted J, Frontoni S, Pop-Busui R, Ziegler D, Kempler P, Freeman R, Low P, Tesfaye S, Valensi P. Methods of investigation for cardiac autonomic dysfunction in human research studies. Diabetes/Metabolism Research and Reviews. 27: 654-64. PMID 21695761 DOI: 10.1002/Dmrr.1224  0.4
2011 Ellingrod VL, Taylor SF, Brook RD, Evans SJ, Zöllner SK, Grove TB, Gardner KM, Bly MJ, Pop-Busui R, Dalack G. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophrenia Research. 130: 20-6. PMID 21504842 DOI: 10.1016/J.Schres.2011.03.031  0.4
2011 Berent-Spillson A, Love T, Pop-Busui R, Sowers M, Persad CC, Pennington KP, Eyvazaddeh AD, Padmanabhan V, Zubieta JK, Smith YR. Insulin resistance influences central opioid activity in polycystic ovary syndrome. Fertility and Sterility. 95: 2494-8. PMID 21486668 DOI: 10.1097/Ogx.0B013E3182402207  0.4
2011 Piya MK, Shivu GN, Tahrani A, Dubb K, Abozguia K, Phan TT, Narendran P, Pop-Busui R, Frenneaux M, Stevens MJ. Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus. Metabolism: Clinical and Experimental. 60: 1115-21. PMID 21306747 DOI: 10.1016/J.Metabol.2010.12.004  0.4
2011 Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, Karter AJ. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 34: 635-40. PMID 21285390 DOI: 10.2337/Dc10-0878  0.4
2011 Berent-Spillson A, Love T, Pop-Busui R, Sowers M, Persad CC, Pennington KP, Eyvazaddeh AD, Padmanabhan V, Zubieta JK, Smith YR. Insulin resistance influences central opioid activity in polycystic ovary syndrome Obstetrical and Gynecological Survey. 66: 693-695. DOI: 10.1097/OGX.0b013e3182402207  0.4
2010 Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 33: 2285-93. PMID 20876709 DOI: 10.2337/Dc10-1303  0.4
2010 Rana JS, Hardison RM, Pop-Busui R, Brooks MM, Jones TL, Nesto RW, Bourassa MG. Resting heart rate and metabolic syndrome in patients with diabetes and coronary artery disease in bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. Preventive Cardiology. 13: 112-6. PMID 20626665 DOI: 10.1111/J.1751-7141.2010.00067.X  0.4
2010 Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, ... ... Pop-Busui R, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 376: 419-30. PMID 20594588 DOI: 10.1016/S0140-6736(10)60576-4  0.4
2010 Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, Waberski BH, Lachin JM, Albers JW. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Current Diabetes Reports. 10: 276-82. PMID 20464532 DOI: 10.1007/S11892-010-0120-8  0.4
2010 Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 33: 1578-84. PMID 20215456 DOI: 10.2337/Dc10-0125  0.4
2010 Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, Waberski BH, Lachin JM. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 33: 1090-6. PMID 20150297 DOI: 10.2337/Dc09-1941  0.4
2010 Calles-Escandón J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 33: 721-7. PMID 20103550 DOI: 10.2337/Dc09-1471  0.4
2010 Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL. The management of diabetic neuropathy in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 55: 365-85. PMID 20042258 DOI: 10.1053/J.Ajkd.2009.10.050  0.4
2010 Pop-Busui R, Simmons Z, Feldman EL. Treatment of Diabetic Neuropathy The Evidence Base For Diabetes Care: Second Edition. 317-340. DOI: 10.1002/9780470682807.ch19  0.4
2009 Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. Journal of the Peripheral Nervous System : Jpns. 14: 257-67. PMID 20021567 DOI: 10.1111/J.1529-8027.2009.00237.X  0.4
2009 Eyvazzadeh AD, Pennington KP, Pop-Busui R, Sowers M, Zubieta JK, Smith YR. The role of the endogenous opioid system in polycystic ovary syndrome. Fertility and Sterility. 92: 1-12. PMID 19560572 DOI: 10.1016/J.Fertnstert.2009.05.012  0.4
2009 Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 119: 2886-93. PMID 19470886 DOI: 10.1161/Circulationaha.108.837369  0.4
2009 Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 58: 1634-40. PMID 19411614 DOI: 10.2337/Db08-1771  0.4
2009 Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ. Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metabolism: Clinical and Experimental. 58: 989-94. PMID 19394661 DOI: 10.1016/J.Metabol.2009.02.020  0.4
2009 Pambianco G, Lombardero M, Bittner V, Forker A, Kennedy F, Krishnaswami A, Mooradian AD, Pop-Busui R, Rana JS, Rodriguez A, Steffes M, Orchard TJ. Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Preventive Cardiology. 12: 9-18. PMID 19301686 DOI: 10.1111/J.1751-7141.2008.00014.X  0.4
2009 Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. American Journal of Physiology. Heart and Circulatory Physiology. 296: H453-61. PMID 19060127 DOI: 10.1152/Ajpheart.00678.2008  0.4
2009 Williams J, Pomeroy NE, Pop-Busui R, Lash R, Douyon L, Chames M, Wyckoff J. Case report: Exenatide use during pregnancy Endocrinologist. 19: 119-121. DOI: 10.1097/Ten.0B013E3181A5875E  0.4
2008 Field MG, Elner VM, Puro DG, Feuerman JM, Musch DC, Pop-Busui R, Hackel R, Heckenlively JR, Petty HR. Rapid, noninvasive detection of diabetes-induced retinal metabolic stress. Archives of Ophthalmology (Chicago, Ill. : 1960). 126: 934-8. PMID 18625939 DOI: 10.1001/Archopht.126.7.934  0.4
2008 Kellogg AP, Cheng HT, Pop-Busui R. Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Current Drug Targets. 9: 68-76. PMID 18220714 DOI: 10.2174/138945008783431691  1
2008 Pop-Busui R, Sullivan KA, Feldman EL. Diabetes and the Nervous System Neurology and General Medicine. 383-407. DOI: 10.1016/B978-044306707-5.50024-9  0.4
2007 Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes. 56: 2997-3005. PMID 17720896 DOI: 10.2337/Db07-0740  0.4
2007 Pop-Busui R, London Z, Kellogg A. 61 – Diabetes and Endocrine Disorders Neurobiology of Disease. 669-680. DOI: 10.1016/B978-012088592-3/50063-3  0.6
2005 Nakashima E, Pop-Busui R, Towns R, Thomas TP, Hosaka Y, Nakamura J, Greene DA, Killen PD, Schroeder J, Larkin DD, Ho YL, Stevens MJ. Regulation of the human taurine transporter by oxidative stress in retinal pigment epithelial cells stably transformed to overexpress aldose reductase. Antioxidants & Redox Signaling. 7: 1530-42. PMID 16356117 DOI: 10.1089/Ars.2005.7.1530  0.4
2005 Kellogg AP, Pop-Busui R. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxidants & Redox Signaling. 7: 1521-9. PMID 16356116 DOI: 10.1089/Ars.2005.7.1521  1
2004 Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, Yamada E, Raffel DM, Stevens MJ. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. Journal of the American College of Cardiology. 44: 2368-74. PMID 15607400 DOI: 10.1016/J.Jacc.2004.09.033  0.4
2002 Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Diabetes. 51: 2619-28. PMID 12145179 DOI: 10.2337/Diabetes.51.8.2619  0.4
2001 Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Experimental Neurology. 168: 259-72. PMID 11259114 DOI: 10.1006/Exnr.2000.7591  0.4
2000 Pop-Busui R, Chey W, Stevens MJ. Severe hypertension induced by the long-acting somatostatin analogue sandostatin LAR in a patient with diabetic autonomic neuropathy Journal of Clinical Endocrinology and Metabolism. 85: 943-946. PMID 10720019 DOI: 10.1210/Jcem.85.3.6401  0.4
Show low-probability matches.